Ligand Pharmaceuticals Incorporated

United States of America


 
Total IP 120
Total IP incl. subs 415 (+ 295 for subs)
Total IP Rank # 10,845
IP Activity Score 2.5/5.0    44
IP Activity Rank # 16,773
IP AS incl. subs 2.6/5.0    136
Stock Symbol
ISIN US53220K5048
Market Cap. 2,400M  (USD)
Industry Biotechnology
Sector Healthcare
Dominant Nice Class Scientific, technological and in...

Patents

Trademarks

46 10
6 4
47 6
1
 
Last Patent 2024 - Unnatural configuration nucleoti...
First Patent 1992 - Use of selective ligands for tre...
Last Trademark 2025 - BEPRO
First Trademark 1995 - LIGAND

Subsidiaries

9 subsidiaries with IP (257 patents, 38 trademarks)

2 subsidiaries without IP

 Register for free to unlock the subsidiary list

Industry (Nice Classification)

Latest Inventions, Goods, Services

2025 G/S Pharmaceutical research and development
2024 G/S Pharmaceutical research and development. Licensing of pharmaceutical products.
G/S Solubilizing chemical agents for use in the manufacture of pharmaceutical preparations; solubili...
G/S Solubilizing chemical agents for use in the manufacture of pharmaceutical preparations; Solubiliz...
2022 Invention Cyclic phosphoramidate compounds. Provided herein are cyclic phosphoramidate compounds, their pre...
Invention Nucleotide prodrug compounds. Provided herein are nucleotide prodrug compounds, their preparation...
Invention Unnatural configuration nucleotide prodrug compounds. Provided herein am phosphoramidate and cyc...
Invention Unnatural configuration nucleotide prodrug compounds. Provided herein are phosphoramidate and cyc...
G/S Pharmaceutical research and development of a process to deliver pharmaceutical preparations.
2021 Invention Heterocycle amines and uses thereof. Compounds and methods in the fields of chemistry and medicin...
Invention Antiviral prodrug compounds. Provided herein are nucleotide prodrug compounds, their preparation...
Invention Antiviral prodrug compounds. Provided herein are nucleotide prodrug compounds, their preparation ...
G/S Pharmaceutical research and development of a process to deliver pharmaceutical preparations
G/S Pharmaceutical research and development Licensing of pharmaceutical products
Invention Benzyloxy phosph(on)ate compounds. Provided herein are 2-substituted benzyloxy phosph(on)ate com...
Invention Benzyloxy phosph(on)ate compounds. Provided herein are 2-substituted benzyloxy phosph(on)ate comp...
2020 Invention Imidazo-fused heterocycles and uses thereof. Compounds and methods in the fields of chemistry and...
Invention Selective androgen receptor modulators (sarms) and uses thereof. Provided herein are compounds, s...
Invention Methods and compositions associated with the granulocyte colony-stimulating factor receptor. Some...
Invention Cyclic phosphate compounds. Provided herein are cyclic phosphate compounds, their preparation an...
Invention Cyclic phosphate compounds. Provided herein are cyclic phosphate compounds, their preparation and...
Invention Crystalline forms and methods of producing crystalline forms of a compound. Disclosed herein are...
Invention Crystalline forms and methods of producing crystalline forms of a compound. Disclosed herein are ...
2019 G/S Pharmaceutical research and development of a process to deliver organ specific pharmaceutical pre...
G/S Pharmaceutical research and development of a process to deliver organ specific pharmaceutical pr...
Invention Methods and compositions for modulating hormone levels. Provided herein are compositions and meth...
Invention Prodrug compounds and their uses. Provided herein are prodrug compounds, their preparation and th...
Invention Glucagon receptor antagonists. Provided herein are solid state forms of compounds, including enan...
Invention Acetal compounds and therapeutic uses thereof. Disclosed herein are acetal and cyclic acetal comp...
2018 Invention Glucagon antagonists. Provided herein are compounds, including enantiomerically pure forms there...
Invention Prodrug compounds and uses thereof. Provided herein are cyclic phosphorus-containing prodrug comp...
Invention Method for treating chronic inflammatory diseases. Methods of administering and pharmaceutical c...
Invention Methods of treatment associated with the granulocyte colony-stimulating factor receptor. Some emb...
2017 Invention Method for treating disorders associated with glomerular function. Methods of administering and p...
Invention Glucagon receptor antagonists. Provided herein are compounds, including enantiomerically pure fo...
Invention Glucagon receptor antagonists. Provided herein are compounds, including enantiomerically pure for...
Invention Derivatives of uridine 5′-cyclophosphate useful to treat hepatitis c viral infections. Some embod...
2016 G/S Licensing of pharmaceutical products
Invention Gemcitabine derivatives. Compositions and methods in the field of medicine and chemistry are disc...
2015 Invention Prodrug compounds and uses therof. Provided herein are cyclic phosphorus-containing prodrug compo...
Invention Glucagon antagonists. Provided herein are compounds, including enantiomerically pure forms thereo...
2001 G/S Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use...
1995 G/S Medicines for the treatment of cancer conditions. Medicines for the treatment of cancer and pre-c...